Exploring the Prevalence and Factors behind Noncompliance to Lifestyle Modification in Hypertensive patients

Abstract

Hypertension, often referred to as the "silent killer," frequently presents no symptoms and remains unnoticed until severe complications arise. It can be likened to an iceberg-like ailment, where the concealed mass of the condition lies beneath the surface, while the visible tip signifies the signs and symptoms. Approximately 30% of individuals with hypertension are unaware of their condition. In the United States, treatment is administered to 59% of those with hypertension, but only 34% manage to maintain their blood pressure within a healthy range. Nevertheless, hypertension can be effectively managed in most instances. According to the World Health Organization, hypertension is defined as having a systolic blood pressure exceeding 140 mmHg or a diastolic blood pressure exceeding 90mmHg. Hypertension poses a substantial risk for various health complications, including stroke, heart attack, heart failure, peripheral arterial disease, aneurysms, and chronic kidney disease. Implementing dietary and lifestyle changes can enhance blood pressure control and reduce the likelihood of associated health issues. This research delves into the prevalence of noncompliance as a significant risk factor in the management of chronic ailments, with a specific focus on antihypertensive therapy. It also investigates the factors contributing to the increased incidence of noncompliance among hypertensive patients. The study's discoveries will equip healthcare professionals with valuable insights to guide their clients effectively and improve compliance. This will be achieved by emphasizing the disease process's importance and the necessity of consistent treatment, offering continuous support, and tailoring interventions based on individual learning needs and challenges.